HealthCare Global Enterprises (NSE:HCG) Valuation Rank


NSE:HCG HealthCare Global Enterprises Ltd NSE:HCG
79 GF Score
Price ₹654.80
GF Value ₹577.84
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is HealthCare Global Enterprises Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

HealthCare Global Enterprises Valuation Rank Related Terms

NSE:HCG
79GF Score
HealthCare Global Enterprises Ltd NSE:HCG
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?

Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued. The current stock price of ₹654.80 is trading 13.3% above its estimated GF Value™ of ₹577.84. GuruFocus considers HealthCare Global Enterprises to be Modestly Overvalued.

Key valuation signals for NSE:HCG:

  • Valuation Rank:
  • GF Value™: ₹577.84 vs. price of ₹654.80 (13.3% above fair value)
  • GF Score™: 79/100 with 2 warning signs

No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HealthCare Global Enterprises Business Description

Other Exchanges 539787:India
Address Mission Road, No. 3, Ground Floor, Tower Block, Unity Building Complex, Bengaluru, KA, IND, 560027
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
79GF Score

Get the complete analysis for NSE:HCG

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹654.80
Price
₹577.84
GF Value